Assessment of immune status of laryngeal squamous cell carcinoma can predict prognosis and guide treatment.
Xueying WangKui CaoErliang GuoXionghui MaoChangming AnLunhua GuoCong ZhangJunnan GuoXianguang YangJi SunWeiwei YangXiaomei LiSusheng MiaoPublished in: Cancer immunology, immunotherapy : CII (2021)
Local and systemic inflammatory markers in patients with laryngeal squamous cell carcinoma are reliable prognostic factors. The risk model and CTSL, KDM5D gene have important potential research value.